2.4.0.6 Html 134 270 1 false 51 0 false 6 false false R1.htm 0000 - Document - Document and Entity Information Sheet http://www.momentapharma.com/role/DocumentAndEntityInformation Document and Entity Information true false R2.htm 0010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Sheet http://www.momentapharma.com/role/BalanceSheet CONDENSED CONSOLIDATED BALANCE SHEETS false false R3.htm 0015 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Sheet http://www.momentapharma.com/role/BalanceSheetParenthetical CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) false false R4.htm 0020 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Sheet http://www.momentapharma.com/role/StatementOfIncome CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS false false R5.htm 0025 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical) Sheet http://www.momentapharma.com/role/StatementOfIncomeParenthetical CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical) false false R6.htm 0030 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS Sheet http://www.momentapharma.com/role/CashFlows CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS false false R7.htm 1010 - Disclosure - The Company Sheet http://www.momentapharma.com/role/DisclosureTheCompany The Company false false R8.htm 1020 - Disclosure - Summary of Significant Accounting Policies Sheet http://www.momentapharma.com/role/DisclosureSummaryOfSignificantAccountingPolicies Summary of Significant Accounting Policies false false R9.htm 1030 - Disclosure - Intangible Assets Sheet http://www.momentapharma.com/role/DisclosureIntangibleAssets Intangible Assets false false R10.htm 1040 - Disclosure - Restricted Cash Sheet http://www.momentapharma.com/role/DisclosureRestrictedCash Restricted Cash false false R11.htm 1050 - Disclosure - Collaboration and License Agreements Sheet http://www.momentapharma.com/role/DisclosureCollaborationAndLicenseAgreements Collaboration and License Agreements false false R12.htm 1060 - Disclosure - Share-Based Payments Sheet http://www.momentapharma.com/role/DisclosureShareBasedPayments Share-Based Payments false false R13.htm 1070 - Disclosure - Tax Incentive Agreement Sheet http://www.momentapharma.com/role/DisclosureTaxIncentiveAgreement Tax Incentive Agreement false false R14.htm 1080 - Disclosure - Related Party Transactions Sheet http://www.momentapharma.com/role/DisclosureRelatedPartyTransactions Related Party Transactions false false R15.htm 1090 - Disclosure - Commitments and Contingencies Sheet http://www.momentapharma.com/role/DisclosureLCommitmentsAndContingencies Commitments and Contingencies false false R16.htm 2020 - Disclosure - Summary of Significant Accounting Policies (Policies) Sheet http://www.momentapharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesPolicies Summary of Significant Accounting Policies (Policies) false false R17.htm 3020 - Disclosure - Summary of Significant Accounting Policies (Tables) Sheet http://www.momentapharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesTables Summary of Significant Accounting Policies (Tables) false false R18.htm 3030 - Disclosure - Intangible Assets (Tables) Sheet http://www.momentapharma.com/role/DisclosureIntangibleAssetsTables Intangible Assets (Tables) false false R19.htm 3050 - Disclosure - Collaboration and License Agreements (Tables) Sheet http://www.momentapharma.com/role/DisclosureCollaborationAndLicenseAgreementsTables Collaboration and License Agreements (Tables) false false R20.htm 3060 - Disclosure - Share-Based Payments (Tables) Sheet http://www.momentapharma.com/role/DisclosureShareBasedPaymentsTables Share-Based Payments (Tables) false false R21.htm 3090 - Disclosure - Commitments and Contingencies (Tables) Sheet http://www.momentapharma.com/role/DisclosureCommitmentsAndContingenciesTables Commitments and Contingencies (Tables) false false R22.htm 4020 - Disclosure - Summary of Significant Accounting Policies (Details) Sheet http://www.momentapharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails Summary of Significant Accounting Policies (Details) false false R23.htm 4021 - Disclosure - Summary of Significant Accounting Policies (Details 2) Sheet http://www.momentapharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails2 Summary of Significant Accounting Policies (Details 2) false false R24.htm 4022 - Disclosure - Summary of Significant Accounting Policies (Details 3) Sheet http://www.momentapharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails3 Summary of Significant Accounting Policies (Details 3) false false R25.htm 4023 - Disclosure - Summary of Significant Accounting Policies (Details 4) Sheet http://www.momentapharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails4 Summary of Significant Accounting Policies (Details 4) false false R26.htm 4024 - Disclosure - Summary of Significant Accounting Policies (Details 5) Sheet http://www.momentapharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails5 Summary of Significant Accounting Policies (Details 5) false false R27.htm 4025 - Disclosure - Summary of Significant Accounting Policies (Details 6) Sheet http://www.momentapharma.com/role/DisclosureSummaryOfSignificantAccountingPoliciesDetails6 Summary of Significant Accounting Policies (Details 6) false false R28.htm 4030 - Disclosure - Intangible Assets (Details) Sheet http://www.momentapharma.com/role/DisclosureIntangibleAssetsDetails Intangible Assets (Details) false false R29.htm 4040 - Disclosure - Restricted Cash (Details) Sheet http://www.momentapharma.com/role/DisclosureRestrictedCashDetails Restricted Cash (Details) false false R30.htm 4050 - Disclosure - Collaboration and License Agreements (Details) Sheet http://www.momentapharma.com/role/DisclosureCollaborationAndLicenseAgreementsDetails Collaboration and License Agreements (Details) false false R31.htm 4060 - Disclosure - Share-Based Payments (Details) Sheet http://www.momentapharma.com/role/DisclosureShareBasedPaymentsDetails Share-Based Payments (Details) false false R32.htm 4061 - Disclosure - Share-Based Payments (Details 2) Sheet http://www.momentapharma.com/role/DisclosureShareBasedPaymentsDetails2 Share-Based Payments (Details 2) false false R33.htm 4070 - Disclosure - Tax Incentive Agreement (Details) Sheet http://www.momentapharma.com/role/DisclosureTaxIncentiveAgreementDetails Tax Incentive Agreement (Details) false false R34.htm 4080 - Disclosure - Related Party Transactions (Details) Sheet http://www.momentapharma.com/role/DisclosureRelatedPartyTransactionsDetails Related Party Transactions (Details) false false R35.htm 4090 - Disclosure - Commitments and Contingencies (Details) Sheet http://www.momentapharma.com/role/DisclosureLCommitmentsAndContingenciesDetails Commitments and Contingencies (Details) false false All Reports Book All Reports Element mnta_CollaborativeArrangementMilestonePaymentsPossible had a mix of decimals attribute values: -6 -5. Element us-gaap_NetIncomeLossAvailableToCommonStockholdersBasic had a mix of decimals attribute values: -5 -3. Element us-gaap_OperatingLeasesFutureMinimumPaymentsDueInThreeYears had a mix of decimals attribute values: -5 -3. Element us-gaap_OperatingLeasesFutureMinimumPaymentsDueInTwoYears had a mix of decimals attribute values: -5 -3. Element us-gaap_ResearchAndDevelopmentExpense had a mix of decimals attribute values: -3 0. Element us-gaap_RestrictedCashAndCashEquivalentsNoncurrent had a mix of decimals attribute values: -5 -3. 'Monetary' elements on report '4021 - Disclosure - Summary of Significant Accounting Policies (Details 2)' had a mix of different decimal attribute values. 'Monetary' elements on report '4030 - Disclosure - Intangible Assets (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '4050 - Disclosure - Collaboration and License Agreements (Details)' had a mix of different decimal attribute values. 'Monetary' elements on report '4061 - Disclosure - Share-Based Payments (Details 2)' had a mix of different decimal attribute values. 'Monetary' elements on report '4090 - Disclosure - Commitments and Contingencies (Details)' had a mix of different decimal attribute values. Process Flow-Through: 0010 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS Process Flow-Through: Removing column 'Mar. 31, 2012' Process Flow-Through: Removing column 'Dec. 31, 2011' Process Flow-Through: 0015 - Statement - CONDENSED CONSOLIDATED BALANCE SHEETS (Parenthetical) Process Flow-Through: 0020 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS Process Flow-Through: 0025 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF COMPREHENSIVE LOSS (Parenthetical) Process Flow-Through: 0030 - Statement - CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS mnta-20130331.xml mnta-20130331.xsd mnta-20130331_cal.xml mnta-20130331_def.xml mnta-20130331_lab.xml mnta-20130331_pre.xml true true